AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT01763099 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Mesenchymal stem cells
Description: Mesenchymal stem cells will be intravenously infused via a central venous catheter(at a dose of 1×10\^6 cells/kg, over 15 min) in day 1 and day 15 of the cycle. If the NEU and PLT levels do not attain the completely response(CR)standards after this cycle, mesenchymal stem cells combined with cord blood will be given. If the NEU and PLT levels attain the completely response(CR)or partly response(PR) standards after this cycle, another cycle with the same strategy will be given.
Study NCT01763099 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Mesenchymal stem cells and cord blood
Description: Mesenchymal stem cells will be given (at a dose of 1×10\^6 cells/kg,intravenously infused via a central venous catheter)on day 1.day 15, day 29 and day 43 of the cycle. Cord blood will be given intravenously infused via a central venous catheter on day 2 of the cycle.
Study NCT00862927 — intervention group
Intervention type: OTHER
Intervention: Breath Sample
Description: Breathe into machine measuring carbon monoxide.
Study NCT00862927 — intervention group
Intervention type: OTHER
Intervention: Saliva Sample
Description: Chew cotton ball for 30 seconds for cotinine measurement.
Study NCT00862927 — intervention group
Intervention type: BEHAVIORAL
Intervention: Questionnaire
Description: 6 surveys, taking approximately 30 minutes total.
Study NCT00862927 — intervention group
Intervention type: BEHAVIORAL
Intervention: View Virtual Reality Scenes
Description: Use virtual reality helmet and hand-held controller to answer questions about 4 viewing scenes while wearing physiological measurement skin sensors, approximately 6 minutes.
Study NCT03324282 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Avelumab
Description: Combination of Gemcitabin-Cisplatin and avelumab given for 6 cycles (each cycle is 21 days)
Study NCT03324282 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GC
Description: Combination of Gemcitabin-Cisplatin given for 6 cycles (each cycle is 21 days)
Study NCT03324282 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: GC
Description: Combination of Gemcitabin-Cisplatin given for 6 cycles (each cycle is 21 days)
Study NCT03268603 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Autologous Adipose-derived Mesenchymal Stromal Cells
Description: The investigational product consists of autologous adipose-derived Mesenchymal Stromal Cells (MSCs), suspended in 5-10 mL Lactated Ringer's. The MSC are provided in a sterile syringe labelled with appropriate patient and product identifiers ready for intrathecal injection.
Study NCT00040885 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: infliximab
Study NCT04153799 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CXCR5 modified EGFR Chimeric Antigen Receptor Autologous T cells
Description: The first dose group: 0.5 × 10\^6/kg CAR positive T cells; The second dose group: 1.58 × 10\^6 / kg CAR positive T cells; The third dose group: 5 × 10\^6/kg CAR positive T cells. The above dose allows a 20 % error; For subjects with body weight greater than 60 kg, the number of cells can only be calculated according to 60 kg of body weight.
Study NCT00040885 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: docetaxel
Study NCT00040885 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: docetaxel
Study NCT01289145 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Motivational intervention
Description: The motivational intervention promotes positive outcome expectancies on physical activity.
Study NCT03506802 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: 18F-FHBG
Description: Given IV
Study NCT03506802 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Aldesleukin
Description: Given SC
Study NCT03506802 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Cellular Therapy
Description: LV-NYESO TCR /sr39TK PBSC and RV-NYESO TCR PBMC given IV
Study NCT03506802 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo PET/CT
Study NCT03506802 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Filgrastim
Description: Given SC
Study NCT03506802 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Laboratory Biomarker Analysis
Description: Correlative studies
Study NCT03506802 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lenalidomide
Description: Given PO
Study NCT03506802 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Leukapheresis
Description: Undergo leukapheresis
Study NCT03506802 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Melphalan
Description: Given IV
Study NCT03506802 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Plerixafor
Description: Given SC
Study NCT03506802 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Positron Emission Tomography
Description: Undergo PET/CT
Study NCT04117386 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: HPV genotyping assay using HPV GenoArray Diagnostic Kits (Hybribio Ltd., Sheung Wan, Hong Kong)
Description: HPV genotyping assay using HPV GenoArray Diagnostic Kits (Hybribio Ltd., Sheung Wan, Hong Kong) for swab sample collected from pterygium and normal conjunctiva and also for urine collected in Colli-PeeTM device (Novosanis, Belgium)
Study NCT04117386 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Bio-Plex® 200 system (Bio- Rad, Hercules, CA)
Description: Bioplex was use for measure cytokine IL-6, IL-18 and VEGF from tears collected from Schirmer strip
Study NCT01289145 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Volitional intervention
Description: The volitional intervention promotes the formulation of action plans for physical activity.
Study NCT01289145 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Active Control
Description: Participants receive a quiz on physical activity and sports.
Study NCT04012788 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Synbiotic mixture
Description: A synbiotic mixture consisting of four probiotic strains and inulin (a prebiotic)
Study NCT03157765 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: endometrial biopsy
Description: endometrial biopsy
Study NCT04674488 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: TILs
Description: a single center, single-arm, open label, interventional study
Study NCT01167660 — intervention group
Intervention type: DEVICE
Intervention: The Thrombo-Monitor (ThM)
Description: Non-invasive measurement of coagulation status and comparison to standard blood coagulation tests. In healthy neonates - immediately after birth, before the administration of vitamin K. Coagulation tests will be done on an umbilical cord blood sample. In sick neonates, coagulation studies will be done according to the medical condition.
Study NCT02750839 — intervention group
Intervention type: PROCEDURE
Intervention: proximal humerus fracture fixation
Description: Mini-invasive proximal humerus fixation with plate, patient in beach chair position, general anesthesia, a small incision lateral to shoulder is made to insert the plate under scope control
Study NCT00212459 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Counseling
Description: Patients are contacted every two weeks after initial counseling to discuss the completion of bleeding records.
Study NCT00212459 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Control
Description: No more contacts are made with control patients after the initial counseling session.
Study NCT03677986 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Video DOT+
Description: Participants will receive financial incentives for recording and submitting videos of themselves taking their daily buprenorphine dose.
Study NCT01130220 — intervention group
Intervention type: OTHER
Intervention: Focus Group
Description: A single focus group will be held until a saturation of themes has been identified.
Study NCT04443855 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Water quality
Description: Hardware: Free supplies chlorine tablets (Aquatabs; NaDCC) and a safe storage vessel to treat and store drinking water.~Promotion: Local promoters will visit study compounds at least monthly to deliver behavior change messages that focus on the treatment of all drinking water for children \< 36 months of age.
Study NCT04443855 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Sanitation
Description: Hardware: Free child potties, sani-scoop hoes to remove feces from household environments, latrine upgrades to a dual pit latrine Promotion: Local promoters will visit study compounds at least monthly to deliver behavior change messages that focus on the use of latrines for defecation and the removal of human and animal feces from the compound.
Study NCT04443855 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Hand washing
Description: Hardware: Hand washing stations, soapy water bottles located at hand washing locations, detergent soap to supply soapy water bottles.~Promotion: Local promoters will visit study compounds at least monthly to deliver behavior change messages that focus on hand washing with soap at critical times around food preparation, defecation, and contact with feces.
Study NCT04443855 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Water quality, Sanitation, Hand washing (Combined WASH)
Description: Hardware: Free supplies Aquatabs; (NaDCC) and a safe storage vessel to treat and store drinking water. Promotion: Local promoters will visit study compounds at least monthly to deliver behavior change messages that focus on the treatment of drinking water for children \< 36 months.~Hardware: Free child potties, sani-scoop hoes to remove feces from household environments, latrine upgrades to a dual pit latrine. Promotion: Local promoters will visit study compounds at least monthly to deliver behavior change messages that focus on the use of latrines for defecation and the removal of human and animal feces from the compound.~Hardware: Hand washing stations, soapy water bottles, detergent soap to supply soapy water bottles. Promotion: Local promoters will visit study compounds at least monthly to deliver behavior change messages that focus on hand washing with soap at critical times as food preparation, defecation, and contact with feces.
Study NCT04443855 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Nutrition
Description: Supplement: Lipid-based Nutrient Supplement (LNS) delivered daily from ages 6 to 24 months.~Promotion: Local promoters will visit study compounds at least monthly to deliver behavior change messages modeled on those recommended in the Guiding Principles for Complementary Feeding of the Breastfed Child and the recent UNICEF Program Guide for Infant and Young Child Feeding Practices.General messages will include (1) practice exclusive breastfeeding from birth to 6 months of age and introduce complementary foods at 6 months of age while continuing to breastfeed; (2) continue breast feeding as you did before receiving LNS; (3) provide your child micronutrient-rich foods such as meat, fish, eggs, and vitamin A rich fruits and vegetables; and (4) feed your child at least 2-3 times per day when 6-8 months old and 3-4 times per day when 9-24 months old.
Study NCT04229940 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Peritoneal bridging
Description: The defect is covered by peritoneal bridging
Study NCT04229940 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: No peritoneal bridging
Description: The defect is left without bridging
Study NCT04412174 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: GC022F
Description: GC022F is a bispecific CAR-T cell immunotherapy that targeted CD19 and CD22. The dosage ranges from 3×10\^5 to 1×10\^6 CAR+T/Kg.
Study NCT01874470 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: renal denervation
Study NCT01874470 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: standard medication
Study NCT01874470 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: standard medication
Study NCT05081778 — intervention group
Intervention type: BEHAVIORAL
Intervention: Obese patient following a medical course
Description: Questionnaires for the assessment of dissociative disorders in obese patients : DES scale of Carlson and Putman, SDQ-20 of Nijenhuis, comorbidities, Dutch Eating Behaviour Questionnaire (DEBQ), questionnaire of Rosenberg
Study NCT03771261 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Weight Loss
Description: Participants will be prescribed hypo-caloric diet by a registered dietitian and attend weekly social support/nutrition education meetings.
Study NCT03771261 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Weight Loss
Description: Participants will be prescribed hypo-caloric diet by a registered dietitian and attend weekly social support/nutrition education meetings.
Study NCT03771261 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Egg Protein
Description: Participants will be provided pre-packaged hard-boiled eggs (3/day, medium) and egg white protein powder.
Study NCT00383500 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Flexitouch
Description: A standard of care intermittent pneumatic compression device (aka, lymphedema pump)
Study NCT00383500 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Class 1 compression garment
Description: Manual lymphatic drainage therapy to provide lymphatic massage, using a Class 1 compression garment supporting the arm during heavy exercise or where the risk of trauma maybe increased (ie, flight, elevation, etc).
Study NCT02923076 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: CCR5 delta32/delta32 cord blood transplantation
Study NCT00208533 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Aripiprazole
Description: Aripiprazole 5 mg to 30mg, individually titrated
Study NCT06583694 — intervention group
Intervention type: BEHAVIORAL
Intervention: Health promotion campaigns to correct the health problems
Study NCT00927238 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: XL TDR
Description: This will be a lateral approach discectomy and reconstruction with the insertion of the XL TDR device.
Study NCT00927238 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Lumbar fusion surgery
Description: Lumbar fusion surgery
Study NCT00927238 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Lumbar fusion surgery
Description: Lumbar fusion surgery
Study NCT04638114 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Mini-open DAA
Description: Direct anterior approach hip
Study NCT04638114 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Mini-open DAA
Description: Direct anterior approach hip
Study NCT04638114 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Hip arthroscopy
Description: arthroscopic treatment of hip pathology
Study NCT04638114 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Hip arthroscopy
Description: arthroscopic treatment of hip pathology
Study NCT06166368 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Diurnal variation
Description: Venous blood samples were obtained under standardized circumstances from 24 healthy young men every third hour through 24 hours, nine time points in total.
Study NCT03305315 — intervention group
Intervention type: OTHER
Intervention: Measurements of jaw movement
Description: Jaw mobility will be measured during simple movements of the mouth (opening the mouth, side-to-side and backwards-and-forwards movement of the jaw). These movements will be measured using a specific apparatus, part of which will be placed on the head like a helmet with the other part placed in the mouth and stuck to the teeth using a dental adhesive. The part in the mouth is specifically designed for this purpose. Measurements using this apparatus will take around 30 minutes.
Study NCT03305315 — intervention group
Intervention type: OTHER
Intervention: Measurement of natural electrical activity of facial muscles
Description: Natural electrical activity of the facial muscles will be measured using electrodes placed on the skin.
Study NCT00151476 — intervention group
Intervention type: DRUG
Intervention: Celecoxib
Description: 800 mg total daily dosing
Study NCT00151476 — intervention group
Intervention type: OTHER
Intervention: Routine Medical Care
Study NCT04443855 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Nutrition, Water quality, Sanitation, Hand washing
Description: Each of the interventions described above for Water Quality, Sanitation \& Hand washing (Combined WASH) Plus the intervention described above for nutrition.
Study NCT03831581 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Erector Spinae Plane Block
Description: In patients with chest pain, ultrasound-guided Erector Spinae Plane Block block was performed at T5 transverse process in the cephalo-caudal direction with Tuohy 18 gauge needle in plane until the needle tip was located in the interfascial plane between the transverse process and the erector spinae muscles, 20 ml of bupivacaine 0.5% was administered and a catheter was inserted if indicated.
Study NCT03931928 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: (Z)-Endoxifen supplementation according to genotype
Description: Group 2: CYP2D6 genotype predicted intermediate metabolizer receive 1.5 mg, poor metabolizer receive 3 mg (Z)-Endoxifen and extensive or ultrarapid metabolizer receive 0 mg endoxifen (Placebo)
Study NCT03931928 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: (Z)-Endoxifen supplementation according to plasma levels
Description: Group 3: Patients will receive (Z)-endoxifen according to (Z)-endoxifen steady state plasma concentrations (phenotype) at screening (i.e. ≤ 15 nM receive 3 mg, > 15 and ≤ 25 nM receive 1.5 mg (Z)-Endoxifen and > 25 nM receive 0 mg (Placebo)
Study NCT00856947 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Cholecalciferol D3
Description: 2 tablets of 1200 IU daily from week 24 of gestation to 1 week after delivery
Study NCT00856947 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo tablet
Description: 2 tablets containing no active substance
Study NCT01552356 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Laboratory Biomarker Analysis
Description: Correlative studies
Study NCT01552356 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pazopanib Hydrochloride
Description: Given PO
Study NCT01552356 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pharmacological Study
Description: Correlative studies
Study NCT04710459 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: cryotherapy
Description: Group 1 included 30 patients, they were subjected to chemoradiotherapy plus endobronchial cryotherapy. Group 2 included include 30 patients, they were subjected to chemoradiotherapy.
Study NCT01567046 — intervention group
Intervention type: OTHER
Intervention: laboratory biomarker analysis
Description: Correlative studies
Study NCT04640792 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Screening or Surveillance Conventionall colonoscopy
Description: Patients in Group A (CC) will undergo Screening or Surveillance Conventual Colonoscopy, Patients in Group B (MEAC) will undergo Screening or Surveillance Colonoscopy with ME-ADPS Device
Study NCT04390711 — intervention group
Intervention type: OTHER
Intervention: High density lipoprotein isolation, detection and in-vitro study.
Description: All blood samples were taken on the day of cardiac catheterization after overnight fasting.High density lipoprotein from each participants was isolated and further collected for carbamylation level detection and in-vitro study.
Study NCT03752502 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Transcranial direct current stimulation (tDCS)
Description: Transcranial direct current stimulation (tDCS) is a noninvasive brain stimulation (NIBS) technique that has been investigated for the management of various chronic pain conditions. However, as a monotherapy for pain relief, this therapy still has controversial results.
Study NCT03752502 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Peripheral electrical stimulation (PES)
Description: Peripheral electrical stimulation (PES) activates a complex neural network involving a series of neurotransmitters and receptors capable of promoting segmental and extrasegmental analgesia.
Study NCT03752502 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Sham tDCS
Description: Transcranial direct current stimulation (tDCS) is a noninvasive brain stimulation (NIBS) technique that has been investigated for the management of various chronic pain conditions. However, as a monotherapy for pain relief, this therapy still has controversial results.
Study NCT00040885 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: placebo
Study NCT03752502 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Sham tDCS
Description: Transcranial direct current stimulation (tDCS) is a noninvasive brain stimulation (NIBS) technique that has been investigated for the management of various chronic pain conditions. However, as a monotherapy for pain relief, this therapy still has controversial results.
Study NCT01365182 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: BF+SUPPORT
Description: A session of biofeedback-assisted pelvic floor muscle exercises (PFME) plus 6 group sessions of the Problem-Solving Therapy (teaching self-management skills).
Study NCT01365182 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: BF+PHONE
Description: A session of biofeedback-assisted pelvic floor muscle exercises (PFME) plus 6 telephone sessions of the Problem-Solving Therapy (teaching self-management skills).